Company / Operating Income per Share
Immunocore Holdings plc Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.91
FY2025
5-year range
-$4.11 / -$0.91
FY2021-FY2025
Trend
+36.1%
vs FY2024
Sector context
#86 of 201
Health Care
What the data says
At $-0.91, Immunocore Holdings plc's operating income per share ranks #86 of 201 in the Health Care sector. Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.91.
Based on SEC 10-K filings.
-0.91 in FY2025.
Improved from $-1.24 to $-0.91 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 201 in Health CareTop 43% of 201This company -$0.91 Sector average -$28.56
▼
+96.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 36.1% year-over-year.
- Ranks #86 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.91 | +36.1% |
| FY2024 | -$1.42 | -14.2% |
| FY2023 | -$1.24 | -9.7% |
| FY2022 | -$1.13 | +72.5% |
| FY2021 | -$4.11 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026